Inside the secondary analysis, the less conservative but clinically meaningful criterion of steady reaction (described like a 50% or more reduction in MADRS from baseline for 2 weeks) was used. On the patients who obtained secure reaction, 25.eight% inside the esketamine group and fifty seven.six% within the placebo group relapsed, https://giosueb222vkz0.mycoolwiki.com/user